1,995 results on '"Leon I"'
Search Results
202. 1105 – Impact of Concurrent Pharmacotherapy with Intragastric Balloons in the Treatment of Obesity
- Author
-
Shah, Shawn L., primary, Hajifathalian, Kaveh, additional, Mehta, Amit, additional, Issa, Danny, additional, Dawod, Enad, additional, Dawod, Qais M., additional, Sampath, Kartik, additional, Mukewar, Saurabh, additional, Mahadev, SriHari, additional, Moore, Rachel L., additional, Tran, Andrew, additional, Kumbhari, Vivek, additional, Agnihotri, Abhishek, additional, Starpoli, Anthony A., additional, Shukla, Alpana, additional, Igel, Leon I., additional, Saunders, Katherine, additional, Kumar, Rekha, additional, Carr-Locke, David L., additional, Aronne, Louis J., additional, and Sharaiha, Reem Z., additional
- Published
- 2019
- Full Text
- View/download PDF
203. Alcohol Use Disorders : A Developmental Science Approach to Etiology
- Author
-
Hiram E. Fitzgerald, Leon I. Puttler, Hiram E. Fitzgerald, and Leon I. Puttler
- Subjects
- Developmental psychology, Alcoholism
- Abstract
Alcohol Use Disorders takes a life-span/developmental approach to understanding the etiologic processes that heighten risk or resilience factors for alcohol use disorders (AUD). Contemporary understanding benefits from thirty years of longitudinal studies that were specifically designed to assess pre-onset origins, predictors of onset, and outcomes through early adulthood. The overriding theme of the volume is that the origins and expression of AUD are best understood within the context of developmental processes and dynamic systems organization and change. Such dynamic systems give rise to diverse pathways that are characterized by multi-finality and equi-finality due to the exchanges among genes, epigenetic processes, and the complexities of the individual organism's experiential world. For some individuals, these dynamic processes lead to risk cumulative or cascade effects that embody adverse childhood experiences that exacerbate risk, predict early onset drinking (or smoking), and are highly likely to lead to AUD during the transitions to adolescence and emerging adulthood. In other cases, protective factors within or outside of the individual's immediate family enable embodiment of normative stress regulatory systems and neural networks that support resilience and prevention of AUD and other addictive behaviors.
- Published
- 2018
204. Los informes de alta hospitalaria médica pueden ser una fuente insuficiente de información para evaluar la calidad de la asistencia
- Author
-
Reyes Domínguez, A., GonzálezBorrego, A., Rojas García, M.F., Montero Chaves, G., Marín León, I., and Lacalle Remigio, J.R.
- Published
- 2001
- Full Text
- View/download PDF
205. La historia clínica en la evaluación de la calidad asistencial de la cardiopatía isquémica: ¿es una fuente de información válida?
- Author
-
Reyes Domínguez, A., Palma Amaro, A., Montero Chaves, G., Rojas García, M.F., Pérez Lozano, M.J., Marín León, I., and Lacalle Remigio, J.R.
- Published
- 2001
- Full Text
- View/download PDF
206. Trends in an obstetric patient population: an eighteen-year study
- Author
-
Amini, Saeid B., Dierker, LeRoy J., Catalano, Patrick M., Ashmead, Graham G., and Mann, Leon I.
- Subjects
Childbirth -- Demographic aspects ,Gestational age -- Statistics ,Birth weight -- Statistics ,Cesarean section -- Statistics ,Health - Abstract
An evaluation of records from 1975 to 1992 at MetroHealth Medical Center in Cleveland found several trends. The hospital is a large inner-city institution serving clinic and private patients and high-risk patients. Information was collected on 63,519 mothers. In the 18-year period, the median maternal age increased from 20 to 23 years. The average gestational age at birth declined from 39.2 weeks to 38.3 weeks, but this was due to a decline in gestational age among clinic patients. Among private patients it increased by a week. The proportion of preterm births increased from 3.3% to 7.8% as did the proportion of low-birth-weight infants (12.7% to 17.3%). Again, the increase in preterm birth was due to an increase among clinic patients; it declined among private patients. The cesarean rate declined from 37% to 25% among private patients but increased from 10% to 17% among clinic patients.
- Published
- 1994
207. Developmental Science, Alcohol Use Disorders, and the Risk–Resilience Continuum
- Author
-
Leon I. Puttler, Robert A. Zucker, and Hiram E. Fitzgerald
- Subjects
Continuum (measurement) ,Developmental Science ,Resilience (network) ,Psychology ,Developmental psychology - Abstract
The origins and expression of addiction are best understood within the context of developmental processes and dynamic systems organization and change. For some individuals, these dynamic processes lead to risk cumulative or cascade effects that embody adverse childhood experiences that exacerbate risk; predict early onset of drinking, smoking, or other substance use; and often lead to a substance use disorder (SUD) during the transitions to adolescence and emergent adulthood. In other cases, protective factors within or outside of the individual’s immediate family enable embodiment of normative stress regulatory systems and neural networks that support resilience and prevention of SUDs. A case study is provided to illustrate these processes and principles of the organization of addictive behavior. Finally, a model of risk to resilience captures the flow of development and the extent to which individual-experience relationships contribute to risk and resilience.
- Published
- 2018
- Full Text
- View/download PDF
208. Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial
- Author
-
Ferrando, C, Soro, M, Unzueta, C, Suarez-Sipmann, F, Canet, J, Librero, J, Pozo, N, Peiro, S, Llombart, A, Leon, I, India, I, Aldecoa, C, Diaz-Cambronero, O, Pestana, D, Redondo, FJ, Garutti, I, Balust, J, Garcia, JI, Ibanez, M, Granell, M, Rodriguez, A, Gallego, L, de la Matta, M, Gonzalez, R, Brunelli, A, Garcia, J, Rovira, L, Barrios, F, Torres, V, Hernandez, S, Gracia, E, Gine, M, Garcia, M, Garcia, N, Miguel, L, Sanchez, S, Pineiro, P, Pujol, R, Garcia-del-Valle, S, Valdivia, J, Hernandez, MJ, Padron, O, Colas, A, Puig, J, Azparren, G, Tusman, G, Villar, J, and Belda, J
- Abstract
Background The effects of individualised perioperative lung-protective ventilation (based on the open-lung approach [OLA]) on postoperative complications is unknown. We aimed to investigate the effects of intraoperative and postoperative ventilatory management in patients scheduled for abdominal surgery, compared with standard protective ventilation. Methods We did this prospective, multicentre, randomised controlled trial in 21 teaching hospitals in Spain. We enrolled patients who were aged 18 years or older, were scheduled to have abdominal surgery with an expected time of longer than 2 h, had intermediate-to-high-risk of developing postoperative pulmonary complications, and who had a body-mass index less than 35 kg/m(2). Patients were randomly assigned (1: 1: 1: 1) online to receive one of four lung-protective ventilation strategies using low tidal volume plus positive end-expiratory pressure (PEEP): open-lung approach (OLA)-iCPAP (individualised intraoperative ventilation [individualised PEEP after a lung recruitment manoeuvre] plus individualised postoperative continuous positive airway pressure [CPAP]), OLA-CPAP (intraoperative individualised ventilation plus postoperative CPAP), STD-CPAP (standard intraoperative ventilation plus postoperative CPAP), or STD-O-2 (standard intraoperative ventilation plus standard postoperative oxygen therapy). Patients were masked to treatment allocation. Investigators were not masked in the operating and postoperative rooms; after 24 h, data were given to a second investigator who was masked to allocations. The primary outcome was a composite of pulmonary and systemic complications during the first 7 postoperative days. We did the primary analysis using the modified intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT02158923. Findings Between Jan 2, 2015, and May 18, 2016, we enrolled 1012 eligible patients. Data were available for 967 patients, whom we included in the final analysis. Risk of pulmonary and systemic complications did not differ for patients in OLA-iCPAP (110 [46%] of 241, relative risk 0.89 [95% CI 0.74-1.07; p=0.25]), OLA-CPAP (111 [47%] of 238, 0.91 [0.76-1.09; p=0.35]), or STD-CPAP groups (118 [48%] of 244, 0.95 [0.80-1.14; p=0.65]) when compared with patients in the STD-O-2 group (125 [51%] of 244). Intraoperatively, PEEP was increased in 69 (14%) of patients in the standard perioperative ventilation groups because of hypoxaemia, and no patients from either of the OLA groups required rescue manoeuvres. Interpretation In patients who have major abdominal surgery, the different perioperative open lung approaches tested in this study did not reduce the risk of postoperative complications when compared with standard lung-protective mechanical ventilation.
- Published
- 2018
209. Longitudinal asymmetry and its effect on pseudorapidity distributions in Pb-Pb collisions at root s(NN)=2.76 TeV
- Author
-
ACHARYA, S, ADAM, J, ADAMOVA, D, ADOLFSSON, J, AGGARWAL, MM, RINELLA, GA, AGNELLO, M, AGRAWAL, N, AHAMMED, Z, AHMAD, N, AHN, SU, AIOLA, S, AKINDINOV, A, AL-TURANY, M, ALAM, SN, ALBA, JLB, ALBUQUERQUE, DSD, ALEKSANDROV, D, ALESSANDRO, B, MOLINA, RA, ALICI, A, ALKIN, A, ALME, J, ALT, T, ALTENKAMPER, L, ALTSYBEEV, I, PRADO, CAG, ANDREI, C, ANDREOU, D, ANDREWS, HA, ANDRONIC, A, ANGUELOV, V, ANSON, C, ANTICIC, T, ANTINORI, F, ANTONIOLI, R, ANWAR, R, APHECETCHE, L, APPELSHAUSER, H, ARCELLI, S, ARNALDI, R, ARNOLD, OW, ARSENE, IC, ARSLANDOK, M, AUDURIER, B, AUGUSTINUS, A, AVERBECK, R, AZMI, MD, BADALA, A, BAEK, YW, BAGNASCO, S, BAILHACHE, R, BALA, R, BALDISSERI, A, BALL, M, BARAL, RC, BARBANO, AM, BARBERA, R, BARILE, F, BARIOGLIO, L, BARNAFOLDI, GG, BARNBY, LS, BARRET, V, BARTALINI, R, BARTH, K, BARTSCH, E, BASILE, M, BASTIDNI, N, BASU, S, BATIGNE, G, BATYUNYA, B, BATZING, R, BEARDEN, IG, BECK, H, BEDDA, C, BEHERA, NK, BELIKOV, I, BELLINI, F, MARTINEZ, HB, BELLWIED, R, BELTRAN, LGE, BELYAEV, V, BENCEDI, G, BEOLE, S, BERCUCI, A, BERDNIKOV, Y, BERENYI, D, BERTENS, RA, BERZANO, D, BETEV, L, BHASIN, A, BHAT, IR, BHATI, AK, BHATTACHARJEE, B, BHOM, J, BIANCHI, A, BIANCHI, L, BIANCHI, N, BIANCHIN, C, BIELCIK, J, BIELCIKOVA, J, BILANDZIC, A, BIRO, G, BISWAS, R, BISWAS, S, BLAIR, JT, BLAU, D, BLUME, C, BOCA, G, BOCK, F, BOGDANOV, A, BOLDIZSAR, L, BOMBARA, M, BONOMI, G, BONORA, M, BOOK, J, BORE, H, BORISSOV, A, BORRI, M, BOTTA, E, BOURJAU, C, BRATRUD, L, BRAUN-MUNZINGER, R, BREGANT, M, BROKER, TA, BROZ, M, BRUCKEN, EJ, BRUNA, E, BRUNO, GE, BUDNIKOV, D, BUESCHING, H, BUFALINO, S, BUHLER, R, BUNCIC, R, BUSCH, O, BUTHELEZI, Z, BUTT, JB, BUXTON, JT, CABALA, J, CAFFARRI, D, CAINES, H, CALIVA, A, VILLAR, E, CAMERINI, R, CAPON, AA, CARENA, F, CARENA, W, CARNESECCHI, F, CASTELLANOS, JC, CASTRO, AJ, CASULA, EAR, SANCHEZ, C, CERELLO, R, CHANDRA, S, CHANG, B, CHAPELAND, S, CHARTIER, M, CHATTOPADHYAY, S, CHAUVIN, A, CHESHKOV, C, CHEYNIS, B, BARROSO, VC, CHINELLATO, DD, CHO, S, CHOCHULA, R, CHOJNACKI, M, CHOUDHURY, S, CHOWDHURY, T, CHRISTAKOGLOU, R, CHRISTENSEN, CH, CHRISTIANSEN, R, CHUJO, T, CHUNG, SU, CICALO, C, CIFARELLI, L, CINDOLO, F, CLEYMANS, J, COLAMARIA, F, COLELLA, D, COLLU, A, COLOCCI, M, CONCAS, M, BALBASTRE, GC, VALLE, ZC, CONNORS, ME, CONTRERAS, JG, CORMIER, TM, MORALES, YC, MALDONADO, IC, CORTESE, R, COSENTINO, MR, COSTA, F, COSTANZA, S, CRKOVSKA, J, CROCHET, R, CUAUTLE, E, CUNQUEIRO, L, DAHMS, T, DAINESE, A, DANISCH, MC, DANU, A, DAS, D, DAS, I, DAS, S, DASH, A, DASH, S, DE, S, CARO, A, CATALDO, G, CONTI, C, CUVELAND, J, FALCO, A, GRUTTOLA, D, MARCO, N, PASQUALE, S, SOUZA, RD, DEGENHARDT, HF, DEISTING, A, DELOFF, A, DEPLANO, C, DHANKHER, R, BARI, D, MAURO, A, NEZZA, R, RUZZA, B, DIETEL, T, DILLENSEGER, R, DIVIA, R, DJUVSLAND, O, DOBRIN, A, GIMENEZ, DD, DONIGUS, B, DORDIC, O, DOREMALEN, LVR, DUBEY, AK, DUBLA, A, DUCROUX, L, DUGGALGS, AK, DUKHISHYAM, M, DUPIEUX, R, EHLERS, RJ, ELIA, D, ENDRESS, E, ENGEL, H, EPPLE, E, ERAZMUS, B, ERHARDT, F, ESPAGNON, B, ESUMI, S, EULISSE, G, EUM, J, EVANS, D, EVDOKIMOV, S, FABBIETTI, L, FAIVRE, J, FANTONI, A, FASEL, M, FELDKAMP, L, FELICIELLO, A, FEOFILOV, G, TELLEZ, AF, FERRETTI, A, FESTANTI, A, FEUILLARD, VJG, FIGIEL, J, FIGUEREDO, MAS, FILCHAGIN, S, FINOGEEV, D, FIONDA, FM, FLORIS, M, FOERTSCH, S, FOKA, R, FOKIN, S, FRAGIACOMO, E, FRANCESCON, A, FRANCISCO, A, FRANKENFELD, U, FRONZE, GG, FUCHS, U, FURGET, C, FURS, A, GIRARD, MF, GAARDHOJE, JJ, GAGLIARDI, M, GAGO, AM, GAJDOSOVA, K, GALLIO, M, GALVAN, CD, GANOTI, R, GARABATOS, C, GARCIA-SOLIS, E, GARG, K, GARGIULO, C, GASIK, R, GAUGER, EF, DUCATI, MBG, GERMAIN, M, GHOSH, J, GHOSH, R, GHOSH, SK, GIANOTTI, R, GIUBELLINO, R, GIUBILATO, R, GLADYSZ-DZIADUS, E, GLASSEL, R, CORA, DMG, RAMIREZ, AG, GONZALEZ, AS, GONZALEZ-ZAMORA, R, GORBUNOV, S, GORLICH, L, GOTOVAC, S, GRABSKI, V, GRACZYKOWSKI, LK, GRAHAM, KL, GREINER, L, GRELLI, A, GRIGORAS, C, GRIGORIEV, V, GRIGORYAN, A, GRIGORYAN, S, GRONEFELD, JM, GROSA, F, GROSSE-OETRINGHAUS, JF, GROSSO, R, GRUBER, L, GUBER, F, GUERNANE, R, GUERZONI, B, GULBRANDSEN, K, GUNJI, T, GUPTA, A, GUPTAW, R, GUZMAN, IB, HAAKE, R, HADJIDAKIS, C, HAMAGAKI, H, HAMAR, G, HAMON, JC, HAGUE, MR, HARRIS, JW, HARTON, A, HASSAN, H, HATZIFOTIADOU, D, HAYASHI, S, HECKEL, ST, HELLBAR, E, HELSTRUP, H, HERGHELEGIU, A, HERNANDEZ, EG, CORRAL, GH, HERRMANN, F, HESS, BA, HETLAND, KF, HILLEMANNS, H, HILLS, C, HIPPOLYTE, B, HLADKY, J, HOHLWEGER, B, HORAK, D, HORNUNG, S, HOSOKAWA, R, HRISTOV, R, HUGHES, C, HUMANIC, TJ, HUSSAIN, N, HUSSAIN, T, HUTTER, D, HWANG, DS, BUITRON, SAI, ILKAEV, R, INABA, M, IPPOLITOV, M, IRFAN, M, ISLAM, MS, IVANOV, M, IVANOV, V, LZUCHEEV, V, JACAK, B, JACAZIO, N, JACOBS, PM, JADHAV, MB, JADLOVSKY, J, JAELANI, S, JAHNKE, C, JAKUBOWSKA, MJ, JANIK, MA, JAYARATHNA, PHSY, JENA, C, JENA, S, JERCIC, M, BUSTAMANTE, RTJ, JONES, PG, JUSKO, A, KALINAK, P, KALWEIT, A, KANG, JH, KAPLIN, V, KAR, S, UYSAL, AK, KARAVICHEV, O, KARAVICHEVA, T, KARAYAN, L, KARCZMARCZYK, R, KARPECHEV, E, KEBSCHULL, U, KEIDEL, R, KEIJDENER, DLD, KEI, M, KETZER, B, KHABANOVA, Z, KHAN, R, KHAN, SA, KHANZADEEV, A, KHARLOV, Y, KHATUN, A, KHUNTIA, A, KIELBOWICZ, MM, KILENG, B, KIM, B, KIM, D, KIM, DJ, KIM, H, KIM, JS, KIM, J, KIM, M, KIM, S, KIM, T, KIRSCH, S, KISE, I, KISELEV, S, KISIEL, A, KISS, G, KLAY, JL, KLEIN, C, KLEIN, J, KLEIN-BOSING, C, KLEWIN, S, KLUGE, A, KNICHEL, ML, KNOSPE, AG, KOBDAJ, C, KOFARAGO, M, KOHLER, MK, KOLLEGGER, T, KONDRATIEV, V, KONDRATYEVA, N, KONDRATYUK, E, KONEVSKIKH, A, KONYUSHIKHIN, M, KOPCIK, M, KOURL, M, KOUZINOPOULOS, C, KOVALENKO, O, KOVALENKO, V, KOWALSKI, M, MEETHALEVEEDU, GK, KRALIK, I, KRAVAKOVA, A, KREIS, L, KRIVDA, M, KRIZEK, F, KRYSHEN, E, KRZEWICKI, M, KUBERA, AM, KTKERA, V, KUHN, C, KUIJER, PG, KUMAR, A, KUMAR, J, KUMAR, L, KUMAR, S, KUNDU, S, KURASHVILI, R, KUREPIN, A, KUREPIN, AB, KURYAKIN, A, KUSHPI, S, KWEON, MJ, KWON, Y, POINTE, SL, ROCCA, R, FERNANDES, CL, LAI, YS, LAKOMOV, I, LANGOY, R, LAPIDUS, K, LARA, C, LARDEUX, A, LATTUCA, A, LAUDI, E, LAVICKA, R, LEA, R, LEARDINI, L, LEE, S, LEHAS, F, LEHNER, S, LEHRBACH, J, LEMMON, RC, LEND, V, LEOGRANDE, E, LEON, I, LEVAI, R, LI, X, LIEN, J, LIETAVA, R, LIM, B, LINDAL, S, LINDENSTRUTH, V, LINDSAY, SW, LIPPMANN, C, LISA, MA, LITICHEVSKYI, V, LLOPE, WJ, LODATO, DF, LOENNE, R, LOGINOV, V, LOIZIDES, C, LONCAR, R, LOPEZ, X, TORRES, EL, LOWE, A, LUETTIG, R, LUHDER, JR, LUNARDON, M, LUPARELLO, G, LUPI, M, LUTZ, TH, MAEVSKAYA, A, MAGER, M, MAHAJAN, S, MAHMOOD, SM, MAIRE, A, MAJKA, RD, MALAEV, M, MALININA, L, MAL'KEVICH, D, MALZACHER, R, MAMONOVMS, A, MANKO, V, MANS, F, MANZARI, V, MAO, Y, MARCHISONE, M, MARES, J, MARGAGLIOTTI, GV, MARGOTTI, A, MARGUTTI, J, MARIN, A, MARKERT, C, MARQUARD, M, MARTIN, NA, MARTINENGO, R, MARTINEZ, JAL, MARTINEZ, MI, GARCIA, GM, PEDREIRA, MM, MASCIOCCHIL, S, MASERA, M, MASONI, A, MASSON, E, MASTROSERIO, A, MATHIS, AM, MATUOKA, PFT, MATYJA, A, MAYER, C, MAZER, J, MAZZILLI, M, MAZZONI, MA, MEDDI, F, MELIKYAN, Y, MENCHACA-ROCHA, A, MENINNO, E, PEREZ, JM, MERES, M, MHLANGA, S, MIAKE, Y, MIESKOLAINEN, MM, MIHAYLOV, DL, MIKHAYLOV, K, MILOSEVIC, J, MISCHKE, A, MISHRA, AN, MISKOWIEC, D, MITRA, J, MITU, CM, MOHAMMADI, N, MOHANTY, B, KHAN, MM, GODOY, DAM, MORENO, LAP, MORETTO, S, MORREALE, A, MORSCH, A, MUCCIFORA, V, MUDNIC, E, MIIHLHEIM, D, MUHURI, S, MUKHERJEE, M, MULLIGAN, JD, MUNHOZ, MG, MUNNING, K, MUNZER, RH, MURAKAMI, H, MURRAY, S, MUSA, L, MUSINSKY, J, MYERS, CJ, MYRCHA, JW, NAG, D, NAIK, B, NAIR, R, NANDI, BK, NANIA, R, NAPPI, E, NARAYAN, A, NARU, MU, LUZ, HN, NATTRASS, C, NAVARRO, SR, NAYAK, K, NAYAK, R, NAYAK, TK, NAZARENKO, S, NEDOSEKIN, A, OLIVEIRA, RAN, NELLEN, L, NESBO, SV, NG, F, NICASSIO, M, NICULESCU, M, NIEDZIELA, J, NIELSEN, BS, NIKOLAEV, S, NIKULIN, S, NIKULIN, V, NOFERINI, F, NOMOKONOV, R, NOOREN, G, NORIS, JCC, NORMAN, J, NYANIN, A, NYSTRAND, J, OESCHLER, H, OH, S, OHLSON, A, OKUBO, T, OLAH, L, OLENIACZ, J, SILVA, ACO, OLIVER, MH, ONDERWAATER, J, OPPEDISANO, C, ORAVA, R, ORAVEC, M, VELASQUEZ, AO, OSKARSSON, A, OTWINOWSKI, J, OYAMA, K, PACHMAYER, Y, PACIK, V, PAGANO, D, PAGANO, R, PAIC, G, PALNI, R, PAN, J, PANDEY, AK, PANEBIANCO, S, PAPIKYAN, V, PAPPALARDO, GS, PAREEK, R, PARK, J, PARMAR, S, PASSFELD, A, PATHAK, SP, PATRA, RN, PAUL, B, PEI, H, PEITZMANN, T, PENG, X, PEREIRA, LG, COSTA, HP, PERESUNKO, D, LEZAMA, EP, PESKOV, V, PESTOV, Y, PETRACEK, V, PETROV, V, PETROVICI, M, PENA, C, PEZZI, RP, PIANO, S, PIKNA, M, PILLOT, R, PIMENTEL, LODL, PINAZZA, O, PINSKY, L, PIYARATHNA, DB, PLOSKON, M, PLANINIC, M, PLIQUETT, F, PLUTA, J, POCHYBOVA, S, PODESTA-LERMA, PLM, POGHOSYANG, MG, POLICHTCHOUK, B, POLJAK, N, POONSAWAT, W, POP, A, POPPENBORE, H, PORTEBOEUF-HOUSSAIS, S, POZDNIAKOV, V, PRASAD, SK, PREGHENELLA, R, PRINO, F, PRUNEAU, CA, PSHENICHNOV, I, PUCCIO, M, PUDDU, G, PUJAHARI, R, PUNIN, V, PUTSCHKE, J, RAHA, S, RAJPUT, S, RAK, J, RAKOTOZAFINDRABE, A, RAMELLO, L, RAMI, F, RANA, DB, RANIWALA, R, RANIWALA, S, RASANEN, SS, RASCANU, BT, RATHEE, D, RATZA, V, RAVASENGA, I, READ, KF, REDLICH, K, REHMAN, A, REICHELT, R, REIDT, F, REN, X, RENFORDT, R, REOLON, AR, RESHETIN, A, REYGERS, K, RIABOV, V, RICCI, RA, RICHERT, T, RICHTER, M, RIEDLER, R, RIEGLER, W, RIGGI, F, RISTEA, C, CAHUANTZI, MR, ROED, K, ROGOCHAYA, E, ROHR, D, ROHRICH, D, ROKITA, R, RONCHETTI, F, ROSAS, ED, ROSNET, R, ROSSI, A, ROTONDI, A, ROUKOUTAKIS, F, ROY, A, ROY, C, ROY, R, RUEDA, OV, RUI, R, RUMYANTSEV, B, RUSTAMOV, A, RYABINKIN, E, RYABOV, Y, RYBICKI, A, SAARINEN, S, SADHU, S, SADOVSKY, S, SAFARIK, K, SAHA, SK, SAHLMULLER, B, SAHOO, B, SAHOO, R, SAHOO, S, SAHU, PK, SAINI, J, SAKAI, S, SALEH, MA, SALZWEDE, J, SAMBYALM, S, SAMSONOV, V, SANDOVAL, A, SARKAR, D, SARKAR, N, SARMA, R, SAS, MHP, SCAPPARONE, E, SCARLASSARA, F, SCHAEFER, B, SCHARENBERG, RP, SCHEID, HS, SCHIAUA, C, SCHICKER, R, SCHMIDT, C, SCHMIDT, HR, SCHMIDT, MO, SCHMIDT, M, SCHMIDT, NV, SCHUKRAFT, J, SCHUTZ, Y, SCHWARZ, K, SCHWEDA, K, SCIOLI, G, SCOMPARIN, E, SEFCIK, M, SEGER, JE, SEKIGUCHI, Y, SEKIHATA, D, SELYUZHENKOV, I, SENOSI, K, SENYUKOV, S, SERRADILLA, E, SETT, R, SEVCENCO, A, SHABANOV, A, SHABETAI, A, SHAHOYAN, R, SHAIKH, W, SHANGARAEV, A, SHARMA, A, SHARMA, M, SHARMA, N, SHEIKH, AI, SHIGAKI, K, SHOU, Q, SHTEJER, K, SIBIRIAK, Y, SIDDHANTA, S, SIELEWICZ, KM, SIEMIARCZUK, T, SILAEVA, S, SILVERMYR, D, SILVESTRE, C, SIMATOVIC, G, SIMONETTI, G, SINGARAJU, R, SINGH, R, SINGHAL, V, SINHA, T, SITAR, B, SITTA, M, SKAALI, TB, SLUPECKI, M, SMIRNOV, N, SNELLINGS, RJM, SNELLMAN, TW, SONG, J, SONG, M, SORAME, F, SORENSEN, S, SOZZI, F, SPIRITI, E, SPUTOWSKA, I, SRIVASTAVA, BK, STACHEL, J, STAN, I, STANKUS, P, STENLUND, E, STOCCO, D, STORETVEDT, MM, STRMEN, R, SUAIDE, AAP, SUGITATE, T, SUIRE, C, SULEYMANOV, M, STLIJIC, M, SULTANOV, R, SUMBERA, M, SUMOWIDAGDO, S, SUZUKI, K, SWAIN, S, SZABO, A, SZARKA, I, TABASSAM, U, TAKAHASHI, J, TAMBAVE, GJ, TANAKA, N, TARHINI, M, TARIQ, M, TARZILA, MG, TAURO, A, MUNOZ, GT, TELESCA, A, TERASAKI, K, TERREVOLI, C, TEYSSIER, B, THAKUR, D, THAKUR, S, THOMAS, D, THORESEN, F, TIEULENT, R, TIKHONOV, A, TIMMINS, AR, TOIA, A, TORRES, SR, TRIPATHY, S, TROGOLO, S, TROMBETTA, G, TROPP, L, TRUBNIKOV, V, TRZASKA, WH, TRZECIAK, BA, TSUJI, T, TUMKIN, A, TURRISI, R, TVETER, TS, ULLALAND, K, UMAKA, EN, URAS, A, USAI, GL, UTROBICIC, A, VALA, M, MAARE, JJD, HOORNE, JW, LEEUWEN, M, VANAT, T, VYVRE, RV, VARGA, D, VARGAS, A, VARGYAS, M, VARMA, R, VASILEIOU, M, VASILIEV, A, VAUTHIER, A, DOCE, OV, VECHERNIN, V, VEEN, AM, VELURE, A, VERCELLIN, E, LIMON, SV, VERNET, R, VERTESI, R, VICKOVIC, L, VIGOLO, S, VIINIKAINEN, J, VILAKAZI, Z, BAILLIE, OV, TELLO, AV, VINOGRADOV, A, VINOGRADOV, L, VIRGILI, T, VISLAVICIUS, V, VODOPYANOV, A, VOLKL, MA, VOLOSHIN, K, VOLOSHIN, SA, VOLPE, G, HALLER, B, VOROBYEV, I, VOSCEK, D, VRANIC, D, VRLAKOVA, J, WAGNER, B, WANG, H, WANG, M, WATANABE, D, WATANABE, Y, WEBER, M, WEBER, SG, WEISER, DF, WENZEL, SC, WESSELS, JP, WESTERHOFF, U, WHITEHEAD, AM, WIECHULA, J, WIKNE, J, WILK, G, WILKINSON, J, WILLEMS, GA, WILLIAMS, MCS, WILLSHER, E, WINDELBAND, B, WITT, WE, YALCIN, S, YAMAKAWA, K, YANG, R, YANO, S, YIN, Z, YOKOYAMA, H, YOO, IK, YOON, JH, YURCHENKO, V, ZACCOLO, V, ZAMAN, A, ZAMPOLLI, C, ZANOLI, HJC, ZARDOSHTI, N, ZAROCHENTSEV, A, ZAVADA, R, ZAVIYALOV, N, ZBROSZCZYK, H, ZHALOV, M, ZHANG, H, ZHANG, X, ZHANG, Y, and ZHANG, C
- Subjects
DENSITY ,CENTRALITY DEPENDENCE - Abstract
First results on the longitudinal asymmetry and its effect on the pseudorapidity distributions in Pb-Pb collisions at root s(NN) = 2.76 TeV at the Large Hadron Collider are obtained with the ALICE detector. The longitudinal asymmetry arises because of an unequal number of participating nucleons from the two colliding nuclei, and is estimated for each event by measuring the energy in the forward neutron-Zero-Degree-Calorimeters (ZNs). The effect of the longitudinal asymmetry is measured on the pseudorapidity distributions of charged particles in the regions vertical bar eta vertical bar < 0.9, 2.8 < eta < 5.1 and -3.7 < eta < -1.7 by taking the ratio of the pseudorapidity distributions from events corresponding to different regions of asymmetry. The coefficients of a polynomial fit to the ratio characterise the effect of the asymmetry. A Monte Carlo simulation using a Glauber model for the colliding nuclei is tuned to reproduce the spectrum in the ZNs and provides a relation between the measurable longitudinal asymmetry and the shift in the rapidity (y(0)) of the participant zone formed by the unequal number of participating nucleons. The dependence of the coefficient of the linear term in the polynomial expansion, c(1), on the mean value of y(0) is investigated. (C) 2018 The Author(s). Published by Elsevier B.V.
- Published
- 2018
210. Obesity Pharmacotherapy
- Author
-
Katherine H. Saunders, Devika Umashanker, Leon I. Igel, Rekha B. Kumar, and Louis J. Aronne
- Subjects
Orlistat ,Phentermine ,030209 endocrinology & metabolism ,General Medicine ,Fructose ,Benzazepines ,Naltrexone ,03 medical and health sciences ,Drug Combinations ,Lactones ,0302 clinical medicine ,Topiramate ,Humans ,030212 general & internal medicine ,Anti-Obesity Agents ,Obesity - Abstract
Although diet, physical activity, and behavioral modifications are the cornerstones of weight management, weight loss achieved by lifestyle modifications alone is often limited and difficult to maintain. Pharmacotherapy for obesity can be considered if patients have a body mass index (BMI) of 30 kg/m
- Published
- 2017
211. Obesity: When to consider medication
- Author
-
Katherine H, Saunders, Alpana P, Shukla, Leon I, Igel, and Louis J, Aronne
- Subjects
Adult ,Male ,Weight Reduction Programs ,Behavior Therapy ,Humans ,Female ,Anti-Obesity Agents ,Obesity ,Middle Aged ,Combined Modality Therapy ,Aged ,Diet Therapy ,Exercise Therapy - Abstract
These 4 cases illustrate how weight loss drugs--including the 4 newest--can be integrated into a treatment plan that includes diet, exercise, and behavior modification.
- Published
- 2017
212. Current and Future Medical Treatment of Obesity
- Author
-
Rekha B. Kumar, Louis J. Aronne, Leon I. Igel, and Devika Umashanker
- Subjects
medicine.medical_specialty ,030209 endocrinology & metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Anti-Obesity Agents ,Pharmacotherapy ,Weight loss ,Weight management ,Weight Loss ,Medicine ,Bariatric Medicine ,Humans ,Obesity ,Intensive care medicine ,business.industry ,Gastroenterology ,medicine.disease ,United States ,Obstructive sleep apnea ,medicine.symptom ,business - Abstract
Obesity is a major health crisis resulting in comorbidities such as hypertension, type 2 diabetes, and obstructive sleep apnea. The need for safe and efficacious drugs to help assist with weight loss and reduce cardiometabolic risk factors is great. With several FDA-approved drugs on the market, there is still a great need to develop long-term obesity treatments or noninvasive oral agents to help assist individuals with obesity when used in conjunction with lifestyle modifications.
- Published
- 2017
213. Use of lorcaserin for glycemic control in patients with type 2 diabetes mellitus
- Author
-
Leon I. Igel and Louis J. Aronne
- Subjects
Blood Glucose ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,MEDLINE ,Medicine (miscellaneous) ,030204 cardiovascular system & hematology ,Lorcaserin ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Glycemic ,Glycated Hemoglobin ,Nutrition and Dietetics ,business.industry ,Type 2 Diabetes Mellitus ,Benzazepines ,medicine.disease ,Diabetes Mellitus, Type 2 ,business ,medicine.drug - Published
- 2017
214. Theory of Mind Among Young Adult Children From Alcoholic Families
- Author
-
Robert A. Zucker, Leon I. Puttler, Maciej Kopera, Marcin Wojnar, Jennifer M. Glass, and Mary M. Heitzeg
- Subjects
Male ,medicine.medical_specialty ,Longitudinal study ,Health (social science) ,Adolescent ,Theory of Mind ,Poison control ,Toxicology ,Young Adult ,Risk Factors ,Injury prevention ,medicine ,Humans ,Longitudinal Studies ,Prospective Studies ,Young adult ,Risk factor ,Family history ,Psychiatry ,Alcohol dependence ,Cognition ,Alcoholism ,Psychiatry and Mental health ,Adult Children ,Female ,Psychology ,Photic Stimulation ,Research Article ,Clinical psychology - Abstract
Given the evidence that several cognitive and emotional functions are impaired in adult alcohol-dependent patients and the possibility that some of these deficits are transmitted to their children, the objective of the present study was to test the hypothesis that the perception of complex mental states would be reduced in young adults from families with a positive family history of alcohol dependence. It was also anticipated that social-perceptual deficits would confer unique predictive ability beyond that shared with other cognitive risk factors for alcohol dependence and/or substance use risk.Data from 301 youth ages 18-21 years, recruited from an ongoing community longitudinal study of alcoholic and matched control families, were analyzed. Family history of alcohol dependence as well as alcohol-dependence diagnosis in the youth was based on diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. A substance use risk factor measured early problem alcohol/other drug use. The perception of mental states was measured with the computerized version of the Reading the Mind in the Eyes Test (RMET).Children of alcohol-dependent parents did not show impairment in the mental states perception task, nor did social perception skills predict alcohol dependence in the youth. Correlational analysis performed between RMET and the substance use risk factor showed no significant association between the variables.The study results do not confirm the hypothesis that behaviorally measured social perception impairment is more prevalent in the children of alcohol-dependent parents. In addition, social-perceptual deficits were not a unique marker of either alcohol dependence or high risk for alcohol dependence in this young adult sample.
- Published
- 2014
- Full Text
- View/download PDF
215. Gender Differences in the Developmental Risk of Onset of Alcohol, Nicotine, and Marijuana Use and the Effects of Nicotine and Marijuana Use on Alcohol Outcomes
- Author
-
Jennifer M. Jester, Robert A. Zucker, Anne Buu, Leon I. Puttler, Agata Dabrowska, and Marjorie Mygrants
- Subjects
Male ,Longitudinal study ,medicine.medical_specialty ,Health (social science) ,Adolescent ,Alcohol Drinking ,Poison control ,Marijuana Smoking ,Toxicology ,Nicotine ,Young Adult ,Surveys and Questionnaires ,Injury prevention ,Humans ,Medicine ,Longitudinal Studies ,Prospective Studies ,Sibling ,Young adult ,Child ,Psychiatry ,Sex Characteristics ,business.industry ,Smoking ,Human factors and ergonomics ,Psychiatry and Mental health ,Female ,business ,Research Article ,Sex characteristics ,medicine.drug - Abstract
This study aimed to (a) characterize gender-specific risk of onset of alcohol, nicotine, and marijuana use developmentally; (b) investigate the effects of early-onset status and frequency of nicotine and marijuana use on alcohol outcomes, controlling for the effects of alcohol use; and (c) examine gender differences in the developmental trajectories of alcohol outcomes and the effects of nicotine and marijuana use on alcohol outcomes.This study conducted secondary analysis on a longitudinal study that recruited at-risk youth through fathers' drunk-driving records and door-to-door canvassing in the midwestern United States. The sample included 160 female-male sibling pairs who were assessed on substance use and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, diagnosis from early childhood to young adulthood.Although males were at higher risk for being early-onset alcohol users, females tended to be at higher risk for initiating marijuana use at younger ages. When early onset and amount of alcohol use were controlled for, early onset of nicotine and marijuana use did not contribute to alcohol outcomes, but frequencies of nicotine and marijuana use did. We also found the associations of quantity/frequency of alcohol and marijuana use with drinking problems to be stronger among females than among males.Higher frequencies of nicotine and marijuana use may contribute to worse alcohol outcomes above and beyond the effect of alcohol use. Females tend to be at higher risk than males for initiating marijuana use and meeting an alcohol use disorder diagnosis at younger ages as well as being more vulnerable to a negative impact of alcohol and marijuana use.
- Published
- 2014
- Full Text
- View/download PDF
216. Changing pension beneficiaries after divorce: it's more important after Kennedy.
- Author
-
Finkel, Leon I. and Bloom, Hailee R.
- Subjects
Divorce -- Laws, regulations and rules ,Pensions -- Laws, regulations and rules ,Pension funds -- Laws, regulations and rules ,Government regulation - Abstract
A recent U.S. Supreme Court decision holds that an ex-spouse can't waive her interest in a former spouse's ERISA-governed pension plan through the divorce decree alone Thus, former spouses must [...]
- Published
- 2009
217. Effect of Food Order on Ghrelin Suppression
- Author
-
Wanda Truong, Leon I. Igel, Alpana P. Shukla, Elizabeth Mauer, Louis J. Aronne, Anthony Casper, Rekha B. Kumar, and Katherine H. Saunders
- Subjects
medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,media_common.quotation_subject ,Blood sugar ,030209 endocrinology & metabolism ,Type 2 diabetes ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Internal Medicine ,Medicine ,030212 general & internal medicine ,media_common ,Advanced and Specialized Nursing ,Meal ,business.industry ,Insulin ,digestive, oral, and skin physiology ,Appetite ,medicine.disease ,Crossover study ,Postprandial ,Endocrinology ,Ghrelin ,business - Abstract
Data suggest that the temporal sequence of carbohydrate ingestion during a meal has a significant impact on postprandial glucose (1–3), insulin, and glucagon-like peptide 1 (GLP-1) excursions (4) in type 2 diabetes, while the effects on ghrelin suppression and satiety have not been reported. The study design and methods have previously been described in detail (4). Briefly, using a crossover design, 16 subjects with overweight/obesity and metformin-treated type 2 diabetes were assigned to consume the same meal on 3 days in random order: Blood was sampled for glucose, insulin, active GLP-1, and total ghrelin measurements at baseline (just before meal ingestion) and at 30-min intervals up to 180 min. Participants rated their hunger and fullness levels using a visual analog …
- Published
- 2018
- Full Text
- View/download PDF
218. 1105 – Impact of Concurrent Pharmacotherapy with Intragastric Balloons in the Treatment of Obesity
- Author
-
Enad Dawod, Rachel L. Moore, Abhishek Agnihotri, Andrew Tran, Reem Z. Sharaiha, Vivek Kumbhari, David L. Carr-Locke, Kaveh Hajifathalian, Qais Dawod, Kartik Sampath, Leon I. Igel, Rekha B. Kumar, Louis J. Aronne, Alpana P. Shukla, Anthony A. Starpoli, Shawn L. Shah, Saurabh Mukewar, Srihari Mahadev, Danny Issa, Amit Mehta, and Katherine H. Saunders
- Subjects
medicine.medical_specialty ,Pharmacotherapy ,Hepatology ,business.industry ,Gastroenterology ,Medicine ,business ,medicine.disease ,Intensive care medicine ,Obesity - Published
- 2019
- Full Text
- View/download PDF
219. Plasma Levels of N Terminal Pro-Brain Natriuretic Peptide as a Prognostic Value in Primary Graft Dysfunction and a Predictor of Mortality in the Immediate Postoperative Period of Lung Transplantation
- Author
-
Leon, I., Vicente, R., Moreno, I., Ramos, F., Solé, A., Morales, P., Vicente, J.L., and Barberá, M.
- Published
- 2009
- Full Text
- View/download PDF
220. Detection of Bottlenecks in Hospital Processes from the XAVIA HIS System using Process Mining
- Author
-
Orellana, A., primary, Davila, C., additional, and Leon, I., additional
- Published
- 2019
- Full Text
- View/download PDF
221. Attosecond Soft-X-Ray Spectroscopy of a Transition Metal Dichalcogenide Material
- Author
-
Buades, B., primary, Leon, I., additional, Di Palo, N., additional, Rivas, D., additional, Sidiropolous, T.P.H., additional, Severino, S., additional, Reduzzi, M., additional, Cousin, S., additional, Hemmer, M., additional, Cocchi, Caterina, additional, Pellegrin, E., additional, Martin, J. Herrero, additional, Mañas-Valero, S., additional, Coronado, E., additional, Danz, T., additional, Draxl, C., additional, Uemoto, M., additional, Yabana, K., additional, Schultze, M., additional, Wall, S., additional, Picon, A., additional, and Biegert, J., additional
- Published
- 2019
- Full Text
- View/download PDF
222. Beyond Survival: The Role of FL Programs in the High Schools and the Two-Year Colleges
- Author
-
Twarog, Leon I.
- Abstract
Presents statistics on foreign language enrollments in two- and four-year colleges and universities and offers suggestions of ways to reverse the trend, particularly outreach to the high schools. (RM)
- Published
- 1977
223. Alcoholic family marital heterogeneity aggregates different child behavior problems both pre- and postseparation
- Author
-
Ip, Ka I, primary, Jester, Jennifer M., additional, Puttler, Leon I., additional, and Zucker, Robert A., additional
- Published
- 2018
- Full Text
- View/download PDF
224. The impact of food order on postprandial glycaemic excursions in prediabetes
- Author
-
Shukla, Alpana P., primary, Dickison, Morgan, additional, Coughlin, Natasha, additional, Karan, Ampadi, additional, Mauer, Elizabeth, additional, Truong, Wanda, additional, Casper, Anthony, additional, Emiliano, Ana B., additional, Kumar, Rekha B., additional, Saunders, Katherine H., additional, Igel, Leon I., additional, and Aronne, Louis J., additional
- Published
- 2018
- Full Text
- View/download PDF
225. Serotype Diversity and Antimicrobial Resistance among Salmonella enterica Isolates from Patients at an Equine Referral Hospital
- Author
-
Leon, I. M., primary, Lawhon, S. D., additional, Norman, K. N., additional, Threadgill, D. S., additional, Ohta, N., additional, Vinasco, J., additional, and Scott, H. M., additional
- Published
- 2018
- Full Text
- View/download PDF
226. Effect of Food Order on Ghrelin Suppression
- Author
-
Shukla, Alpana P., primary, Mauer, Elizabeth, additional, Igel, Leon I., additional, Truong, Wanda, additional, Casper, Anthony, additional, Kumar, Rekha B., additional, Saunders, Katherine H., additional, and Aronne, Louis J., additional
- Published
- 2018
- Full Text
- View/download PDF
227. Benign Fibroepithelial Polyps: A Rare Cause of Ureteropelvic Junction Obstruction in Children
- Author
-
Vaidehi Agrawal, Anitha Ezekiel, Elena Romero, and Leon I. Smith-Harrison
- Subjects
Renal ultrasound ,medicine.medical_specialty ,Flank pain ,MAG3 scan, Mercaptoacetyltriglycine 3 scan ,Urology ,Urinary system ,FEP, Fibroepithelial polyps ,Less invasive ,Ureteropelvic junction ,Hydronephrosis ,lcsh:RC870-923 ,Pediatrics ,Polyps ,medicine ,Fibroepithelial Polyp ,UPJ, ureteropelvic junction ,business.industry ,lcsh:Diseases of the genitourinary system. Urology ,medicine.disease ,Pediatric urology ,Surgery ,medicine.anatomical_structure ,UPJ obstruction ,business ,Urinary tract obstruction - Abstract
FEPs are rare, benign mucosal growths that may cause urinary tract obstruction in both adults and children. We present the case of a ten year old Hispanic male with recurring urinary tract infections and hydronephrosis diagnosed with fibroepithelial polyps (FEPs). Despite multiple radiographic procedures, we were unable to accurately preoperatively diagnose FEPs. Here we demonstrate the difficulties in preoperative diagnosis and suggest that perhaps a combination of US and MRI in the setting of persistent urinary tract infections and flank pain may be the best approach for early diagnosis and conservative management, including less invasive treatment protocols.
- Published
- 2015
- Full Text
- View/download PDF
228. Implementation of Management Initiative Decision (Mid) 913 - Background and Impact within DOD
- Author
-
Smith, Leon I., primary
- Published
- 2004
- Full Text
- View/download PDF
229. Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial
- Author
-
Sergio Fragoso-Saavedra, Isaac Núñez, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Daniel Manzur-Sandoval, Alejandro Quintero-Villegas, H. Benjamín García-González, Sergio L. Carbajal-Morelos, Sergio PoncedeLeón-Rosales, José Gotés-Palazuelos, José A. Maza-Larrea, J. Javier Rosales-de la Rosa, Dafne Diaz-Rivera, Edgar Luna-García, Elvira Piten-Isidro, Perla M. Del Río-Estrada, Mario Fragoso-Saavedra, Yanink Caro-Vega, Isabella Batina, León Islas-Weinstein, David A. Iruegas-Nunez, Juan J. Calva, Pablo F. Belaunzarán-Zamudio, Juan Sierra-Madero, José C. Crispín, and Sergio Iván Valdés-Ferrer
- Subjects
COVID-19 ,SARS-CoV-2 ,Mortality ,Invasive mechanical ventilation ,Immunomodulation ,Pyridostigmine ,Therapeutics. Pharmacology ,RM1-950 ,Biochemistry ,QD415-436 - Abstract
Abstract: Background: Respiratory failure in severe coronavirus disease 2019 (COVID-19) is associated with a severe inflammatory response. Acetylcholine (ACh) reduces systemic inflammation in experimental bacterial and viral infections. Pyridostigmine increases the half-life of endogenous ACh, potentially reducing systemic inflammation. We aimed to determine if pyridostigmine decreases a composite outcome of invasive mechanical ventilation (IMV) and death in adult patients with severe COVID-19. Methods: We performed a double-blinded, placebo-controlled, phase 2/3 randomized controlled trial of oral pyridostigmine (60 mg/day) or placebo as add-on therapy in adult patients admitted due to confirmed severe COVID-19 not requiring IMV at enrollment. The primary outcome was a composite of IMV or death by day 28. Secondary outcomes included reduction of inflammatory markers and circulating cytokines, and 90-day mortality. Adverse events (AEs) related to study treatment were documented and described. Results: We recruited 188 participants (94 per group); 112 (59.6%) were men; the median (IQR) age was 52 (44–64) years. The study was terminated early due to a significant reduction in the primary outcome in the treatment arm and increased difficulty with recruitment. The primary outcome occurred in 22 (23.4%) participants in the placebo group vs. 11 (11.7%) in the pyridostigmine group (hazard ratio, 0.47, 95% confidence interval 0.24–0.9; P = 0.03). This effect was driven by a reduction in mortality (19 vs. 8 deaths, respectively). Conclusion: Our data indicate that adding pyridostigmine to standard care reduces mortality among patients hospitalized for severe COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
230. In-vitro evaluation of an experimental method for bonding of orthodontic brackets with self-adhesive resin cements
- Author
-
Mohsen Merati, Leon I. Dogon, Hooman Shafaee, Baratali Ramazanzadeh, and Keyvan Sohrabi
- Subjects
Cement ,Materials science ,Enamel paint ,business.industry ,Bracket ,technology, industry, and agriculture ,Dentistry ,Article ,Demineralization ,Orthodontic brackets ,chemistry.chemical_compound ,Self adhesive ,stomatognathic system ,chemistry ,Fluoride release ,visual_art ,visual_art.visual_art_medium ,business ,General Dentistry ,Fluoride - Abstract
Background: Self-adhesive resin cements do not require the surface treatment of teeth and are said to release fluoride, which makes them suitable candidates for bonding of orthodontic brackets. The objectives of this study was to investigate the shear bond strength (SBS) of self-adhesive resin cements on etched on non-etched surfaces in vitro and to assess their fluoride release features. Materials and Methods: Four fluoride-releasing dual-cure self-adhesive resin cements were investigated. For SBS experiment, 135 freshly extracted human maxillary premolars were used and divided into nine groups of 15 teeth. In the control group, brackets were cemented by Transbond XT (3M Unitek, USA), in four groups self-adhesive resin cements were used without acid-etching and in four groups self-adhesive cements were applied on acid-etched surfaces and the brackets were then deboned in shear with a testing machine. Adhesive remnant index (ARI) scores were also calculated. For fluoride release investigation, 6 discs were prepared for each self-adhesive cement. Transbond XT and Fuji Ortho LC (GC, Japan) served as negative and positive control groups, respectively. The fluoride release of each disc into 5 ml of de-ionized water was measured at days 1, 2, 3, 7, 14, 28, and 56 using a fluoride ion-selective electrode connected to an ion analyzer. To prevent cumulative measurements, the storage solutions were changed daily. Results: The SBS of brackets cemented with Transbond XT were significantly higher compared to self-adhesives applied on non-etched surfaces (P
- Published
- 2013
- Full Text
- View/download PDF
231. What Are the Issues? A Colloquium
- Author
-
Bonham, George W., McKinney, Robert, Peterson, Chip F., Gilman, Richard C., Jungkuntz, Richard, Colton, Joel, White, Barbara M., Lopez, George A., Perkins, James A., Fersh, Seymour, Eskow, Stephen, Twarog, Leon I., Eddy, Peter, and Torney, Judith V.
- Published
- 1980
232. Dopamine And Dobutamine
- Author
-
Goldberg, Leon I. and Yates, Alan
- Published
- 1978
233. Looking Back with Longing in Hebrew Fiction
- Author
-
Yudkin, Leon I.
- Published
- 1986
- Full Text
- View/download PDF
234. JURIJ NAGIBIN'S LECTURE TOUR: (A) Munir Sendich, Introductory Note; (B) Ju. M. Nagibin, Two-Month Lecture Tour of United States Universities and Colleges; (C) Letters by Participating Hosts
- Author
-
Sendich, Munir, Nagibin, Ju. M., Pratt, Sarah, Нагибин, Юрий, Gibian, George, Belknap, Robert L., Orth, Samuel F., Harris, Jane G., Beard, Robert E., Gove, Antonina Filonov, Mitelman, Nina, Porter, Richard Noel, Debreczeny, Paul, Milivojevič, Dragan, Dunkel, Alexander, Rogers, Thomas F., Lee, C. Nicholas, Filips-Juswigg, K., Armes, Keith, Зрещенский, Д. Н., Twarog, Leon I., Frisque, Mary A., and Thompson, William F.
- Published
- 1979
235. Evaluación del sistema financiero mexicano
- Author
-
León I., Osear and Pacheco I., Daniel
- Published
- 1995
236. Antiquities Legislation Pending in Congress
- Author
-
Pomerance, Leon I. and Muscarella, Oscar White
- Published
- 1976
237. Application of new diterpane biomarkers to source, biodegradation and mixing effects on Central Llanos Basin oils, Colombia
- Author
-
Dzou, Leon I., Holba, Albert G., Ramón, Juan C., Moldowan, J.Michael, and Zinniker, David
- Published
- 1999
- Full Text
- View/download PDF
238. Interactive design language: A unified approach to hardware simulation, synthesis and documentation.
- Author
-
Leon I. Maissel and Daniel L. Ostapko
- Published
- 1982
- Full Text
- View/download PDF
239. The Relationship of Receptor Actions of Dopamine Agonists to Their Clinical Effects
- Author
-
Goldberg, Leon I., Poste, George, editor, and Crooke, Stanley T., editor
- Published
- 1984
- Full Text
- View/download PDF
240. Die Flunitrazepam N2O-Narkose in der Neuroradiologie
- Author
-
Tolksdorf, W., Hartung, H. J., Leon, I., Lutz, H., Bergmann, H., editor, Brückner, J. B., editor, Gemperle, M., editor, Mayrhofer, O., editor, Frey, R., editor, Henschel, W. F., editor, Peter, K., editor, Weis, Karl-Heinz, editor, and Cunitz, Günther, editor
- Published
- 1980
- Full Text
- View/download PDF
241. Sympathomimetic Amines in the Treatment of Shock
- Author
-
Goldberg, Leon I., Rajfer, Sol I., and Maronde, Robert F., editor
- Published
- 1986
- Full Text
- View/download PDF
242. Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study
- Author
-
Isaac Núñez, Joshua Gillard, Sergio Fragoso-Saavedra, Dorien Feyaerts, León Islas-Weinstein, Angel A. Gallegos-Guzmán, Uriel Valente-García, Justin Meyerowitz, J. Daniel Kelly, Han Chen, Edward Ganio, Alexander Benkendorff, Jaime Flores-Gouyonnet, Pedro Dammann-Beltrán, José Francisco Heredia-González, Gabriela A. Rangel-Gutiérrez, Catherine A. Blish, Kari C. Nadeau, Garry Nolan, Jose C. Crispín, David R. McIlwain, Brice Gaudillière, and Sergio I. Valdés-Ferrer
- Subjects
post-COVID-19 conditions ,long COVID ,persistent COVID ,SARS-CoV-2 ,Mexico ,Medicine (General) ,R5-920 - Abstract
IntroductionFew studies have evaluated the presence of Post COVID-19 conditions (PCC) in people from Latin America, a region that has been heavily afflicted by the COVID-19 pandemic. In this study, we describe the frequency, co-occurrence, predictors, and duration of 23 symptoms in a cohort of Mexican patients with PCC.MethodsWe prospectively enrolled and followed adult patients hospitalized for severe COVID-19 at a tertiary care centre in Mexico City. The incidence of PCC symptoms was determined using questionnaires. Unsupervised clustering of PCC symptom co-occurrence and Kaplan–Meier analyses of symptom persistence were performed. The effect of baseline clinical characteristics was evaluated using Cox regression models and reported with hazard ratios (HR).ResultsWe found that amongst 192 patients with PCC, respiratory problems were the most prevalent and commonly co-occurred with functional activity impairment. 56% had ≥5 persistent symptoms. Symptom persistence probability at 360 days 0.78. Prior SARS-CoV-2 vaccination and infection during the Delta variant wave were associated with a shorter duration of PCC. Male sex was associated with a shorter duration of functional activity impairment and respiratory symptoms. Hypertension and diabetes were associated with a longer duration of functional impairment. Previous vaccination accelerated PCC recovery.DiscussionIn our cohort, PCC symptoms were frequent (particularly respiratory and neurocognitive ones) and persistent. Importantly, prior SARS-CoV-2 vaccination resulted in a shorter duration of PCC.
- Published
- 2023
- Full Text
- View/download PDF
243. Drug-induced weight gain: Rethinking our choices
- Author
-
Katherine H, Saunders, Leon I, Igel, Alpana P, Shukla, and Louis J, Aronne
- Subjects
Adult ,Male ,Prescription Drugs ,Treatment Outcome ,Drug-Related Side Effects and Adverse Reactions ,Practice Guidelines as Topic ,Humans ,Female ,Middle Aged ,Overweight ,Weight Gain - Abstract
Weight gain secondary to medications is a potentially modifiable risk. Here's how to optimize drug choices for patients with several common conditions.
- Published
- 2017
244. Open lung approach versus standard protective strategies: Effects on driving pressure and ventilatory efficiency during anesthesia - A pilot, randomized controlled trial
- Author
-
Ferrando C, Suarez-Sipmann F, Tusman G, Leon I, Romero E, Gracia E, Mugarra A, Arocas B, Pozo N, Soro M, and Belda F
- Published
- 2017
245. BOYS, EARLY RISK FACTORS FOR ALCOHOL PROBLEMS, AND THE DEVELOPMENT OF THE SELF: AN INTERCONNECTED MATRIX
- Author
-
Leon I, Puttler, Hiram E, Fitzgerald, Mary M, Heitzeg, and Robert A, Zucker
- Subjects
Male ,Parents ,Adolescent ,Models, Psychological ,Vulnerable Populations ,Self Concept ,Article ,Child Development ,Risk Factors ,Child, Preschool ,Humans ,Prospective Studies ,Child ,Alcohol-Related Disorders ,Stress, Psychological - Abstract
Alcohol Use Disorders (AUDs) are a major public health issue worldwide. Although drinking and problematic alcohol use usually begins during adolescence, developmental origins of the disorder can be traced back to infancy and early childhood. Identification of early risk factors is essential to understanding developmental origins. Using data from the Michigan Longitudinal Study, an ongoing, prospective, high-risk family study, this paper summarizes findings of family context and functioning of both children and parents. We draw attention to the development of the self, an understudied aspect of very young children being reared in alcoholic families that exacerbates exposure to high childhood adverse experiences. We also provide evidence demonstrating that young boys are embedded in a dynamic system of genes, epigenetic processes, brain organization, family dynamics, peers, community, and culture that strengthens risky developmental pathways if nothing is done to intervene during infancy and early childhood.
- Published
- 2016
246. Practical Use of Pharmacotherapy for Obesity
- Author
-
Leon I. Igel, Katherine H. Saunders, Louis J. Aronne, and Rekha B. Kumar
- Subjects
medicine.medical_specialty ,Phentermine ,030209 endocrinology & metabolism ,Fructose ,Pharmacology ,Weight Gain ,03 medical and health sciences ,Lactones ,0302 clinical medicine ,Pharmacotherapy ,Weight loss ,Topiramate ,Weight management ,Appetite Depressants ,medicine ,Humans ,Hypoglycemic Agents ,Testosterone ,030212 general & internal medicine ,Obesity ,Risk factor ,Intensive care medicine ,Bupropion ,Antihypertensive Agents ,Orlistat ,Hepatology ,business.industry ,Hypogonadism ,Gastroenterology ,Testosterone (patch) ,Benzazepines ,Liraglutide ,medicine.disease ,Antidepressive Agents ,Naltrexone ,Drug Combinations ,Androgens ,Anti-Obesity Agents ,medicine.symptom ,business ,Body mass index ,Weight gain ,Antipsychotic Agents - Abstract
Obesity management requires a multidisciplinary approach, as there are many factors that contribute to the development of obesity, as well as the preservation of excess weight once it has been gained. Diet, exercise, and behavior modification are key components of treatment. In addition to lifestyle changes, weight gain secondary to medications is an important modifiable risk factor. Even after appropriate lifestyle modification, and medication adjustments (where possible) to avoid agents that can contribute to weight gain, many patients are still unable to achieve clinically meaningful weight loss. Pharmacotherapy for obesity management can fill an important role for these patients. This article will review medications that can lead to weight gain and potential alternatives, currently approved anti-obesity medications and best practices to individualize the selection process, and the use of testosterone in men with hypogonadism and obesity.
- Published
- 2016
247. Endoscopic Sleeve Gastroplasty Significantly Reduces Body Mass Index and Metabolic Complications in Obese Patients
- Author
-
Leon I. Igel, Nikhil A. Kumta, Alpana P. Shukla, Elizabeth C. Verna, Monica Saumoy, Amit P. Desai, Louis J. Aronne, Robert E. Schwartz, Christina Frissora, Rekha B. Kumar, Michel Kahaleh, Andrea Benevenuto, Reem Z. Sharaiha, Alex M. Sarkisian, and Amy Tyberg
- Subjects
Adult ,Male ,medicine.medical_specialty ,Waist ,Gastroplasty ,Body Mass Index ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Weight loss ,Diabetes mellitus ,medicine ,Diabetes Mellitus ,Humans ,Obesity ,Prospective Studies ,Prospective cohort study ,Aged ,Hypertriglyceridemia ,Hepatology ,business.industry ,Metabolic disorder ,Gastroenterology ,Middle Aged ,medicine.disease ,Curvatures of the stomach ,Surgery ,Blood pressure ,Treatment Outcome ,030220 oncology & carcinogenesis ,Hypertension ,030211 gastroenterology & hepatology ,Female ,medicine.symptom ,business ,Body mass index - Abstract
Background & Aims Endoscopic sleeve gastroplasty (ESG) is an incisionless, minimally invasive bariatric procedure that reduces the length and width of the gastric cavity to facilitate weight loss. We performed a prospective study to evaluate the effects of ESG on total body weight loss and obesity-related comorbidities. Methods We collected data from 91 consecutive patients (mean age, 43.86 ± 11.26 years; 68% female) undergoing ESG from August 2013 through March 2016. All patients had a body mass index (BMI) greater than 30 kg/m 2 and had failed noninvasive weight-loss measures or had a BMI greater than 40 kg/m 2 and were not considered as surgical candidates or refused surgery. All procedures were performed with a cap-based flexible endoscopic suturing system to facilitate a triangular pattern of sutures to imbricate the greater curvature of the stomach. Patients were evaluated after 6 months (n = 73), 12 months (n = 53), and 24 months (n = 12) for anthropometric features (BMI, weight, waist circumference, blood pressure) and underwent serologic (hemoglobin A1c), lipid panel, serum triglycerides, and liver function tests. The primary outcomes were total body weight loss at 6, 12, and 24 months. Secondary outcomes were the effects of ESG on metabolic factors (blood pressure, diabetes, hyperlipidemia, steatohepatitis) and safety. Results The patients' mean BMI before the procedure was 40.7 ± 7.0 kg/m 2 . Patients had lost 14.4% of their total body weight at 6 months (80% follow-up rate), 17.6% at 12 months (76% follow-up rate), and 20.9% at 24 months (66% follow-up rate) after ESG. At 12 months after ESG, patients had statistically significant reductions in levels of hemoglobin A1c ( P = .01), systolic blood pressure ( P = .02), waist circumference ( P P P = .02). However, there was no significant change in low-density lipoprotein after vs before ESG ( P = .79). There was one serious adverse event (1.1%) (perigastric leak) that occurred that was managed non-operatively. Conclusions ESG is a minimally invasive and effective endoscopic weight loss intervention. In addition to sustained total body weight loss up to 24 months, ESG reduced markers of hypertension, diabetes, and hypertriglyceridemia.
- Published
- 2016
248. Siblings, schooling, work and drought
- Author
-
Galab, S and Outes-Leon, I
- Subjects
Health and health policy ,Early and Child learning ,Economics and education ,Families,children and childcare ,Poverty ,Education - Abstract
In this paper we explore the effect that a recent drought in Andhra Pradesh, India, has had on the school and work patterns of children aged 11 to 12 years. Previous empirical studies have investigated the effect of shocks on outcomes for children but few have allowed for heterogeneous treatment effects across children. Ignoring such heterogeneity might lead to biases in the estimated impact of the shocks. The aim of this paper is to address this lacuna. Using data from Young Lives, a longitudinal cohort study of children, we estimate the average impact of the drought on participation in schooling. We then expand our empirical model to allow for heterogeneous effects across children of different demographic categories – namely gender and birth order. Our analysis shows that ignoring child heterogeneity would underestimate the severity of the effect of the drought on children’s welfare and human capital accumulation. In particular, we find that the drought significantly reduced the time spent on schooling by most demographic groups. The exception is the group most likely to have been involved in agricultural work when there is no drought; the schooling participation of eldest sons appears to increase because of the drought. Furthermore, we trace the impact of the drought on child labour and cognitive development, while we rule out the possibility that the uncovered heterogeneous patterns might be driven by social norms or cultural biases in favour of eldest sons.
- Published
- 2016
249. The Israeli Writer and the Holocaust
- Author
-
Yudkin, Leon I.
- Published
- 1973
250. Appelfeld's Dream of Europe
- Author
-
Yudkin, Leon I.
- Published
- 1971
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.